Cholinoceptor activating drugs
Download
1 / 77

Cholinoceptor activating drugs - PowerPoint PPT Presentation


  • 731 Views
  • Updated On :

Cholinoceptor activating drugs. M.R. Zarrindast. Cholinergic Receptors: Where are they? . Postganglionic parasympathetic neuroeffector junctions All autonomic ganglia At the neuromuscular endplate. Cholinergic Receptors: Types. Muscarinic receptors Nicotinic receptors

Related searches for Cholinoceptor activating drugs

loader
I am the owner, or an agent authorized to act on behalf of the owner, of the copyrighted work described.
capcha
Download Presentation

PowerPoint Slideshow about 'Cholinoceptor activating drugs' - darrion


An Image/Link below is provided (as is) to download presentation

Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author.While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server.


- - - - - - - - - - - - - - - - - - - - - - - - - - E N D - - - - - - - - - - - - - - - - - - - - - - - - - -
Presentation Transcript

Cholinergic receptors where are they l.jpg
Cholinergic Receptors: Where are they?

  • Postganglionic parasympathetic neuroeffector junctions

  • All autonomic ganglia

  • At the neuromuscular endplate


Cholinergic receptors types l.jpg
Cholinergic Receptors: Types

  • Muscarinic receptors

  • Nicotinic receptors

    Based on selective activation and antagonism.



Muscarinic receptors stimulated by muscarine l.jpg
Muscarinic receptors(Stimulated by muscarine)

  • on cells innervated by PNS

    • smooth muscle

    • heart

    • exocrine glands

  • endothelial cells of the vascular beds (even though these are not innervated)

  • brain


Nicotinic receptors stimulated by nicotine l.jpg
Nicotinic receptors(Stimulated by nicotine)

  • autonomic ganglia - CNS & PNS

  • neuromuscular junction (somatic nerves)

  • brain – esp. the spinal cord



Cholinergic agonists l.jpg
Cholinergic agonists

  • Two (2) types

    • Direct –

      • occupy and activate receptors

    • Indirect

      • inhibit acetylcholinesterase

      • levels of Ach increase

      • Ach stimulates receptors



Esters of choline l.jpg
Esters of Choline

  • hydrophilic

  • differ in breakdown by Ach’esterase

    • acetylcholine - very susceptable

    • methacholine - 3X less susceptible

    • bethanechol - not susceptible

  • methacholine & bethanechol

    • longer duration of action than Ach

    • mostly activate muscarinic receptors


Direct l.jpg
Direct

  • Esters of choline – mostly activate muscarinic receptors

    • methacholine

    • bethanechol

  • Alkaloids – activate both muscarinic and nicotinic receptors

    • pilocarpine

    • nicotine



Alkaloids pilocarpine and nicotine l.jpg
Alkaloids(pilocarpine and nicotine)

  • Highly lipid soluble

    • well absorbed from GI tract

    • get into brain

  • Capable of both muscarinic and nicotinic receptor activation


Nicotinic to depolarizing blockade receptors are susceptible l.jpg
Nicotinic to depolarizing blockade receptors are susceptible

  • depolarizes ganglion cell or neuromuscular endplate

  • if present in high concentration, they produce a “depolarizing block”

    • neuron or endplate stays depolarized

    • skeletal muscle relaxation

    • ganglia of both PNS & SNS systems may be paralyzed


Effects of muscarinic agonists l.jpg
Effects of Muscarinic Agonists

  • Eye

  • Cardiovascular system

    • Heart

    • Blood vessels

  • Respiratory tract

  • Gastrointestinal tract



Slide24 l.jpg
Eye

  • pupillary sphincter muscle contraction (miosis)

  • ciliary muscle contraction

    • opens drainage canals in anterior chamber

    • lowers intraocular pressure

    • lens thickens for near vision


Cv effects l.jpg
CV Effects

  • Direct effects on heart

    • decreased SA and AV conduction velocity

    • decreased force of atrial contraction

  • Reduced vascular resistance –

    • activation of receptors on endothelium

    • generation of nitric oxide (NO)

    • NO causes vascular muscle relaxation

  • Effects on BP modified by reflexes


Cardiac conduction ach l.jpg
Cardiac Conduction - Ach

  • Increased K+ conduction – slows conduction

    • SA node

    • AV node

  • Decreased inward Ca++ current – reduces force of contraction

  • Slowed pacemaker rate opposed by reflexes

  • Ventricles are less directly affected (parasympathetic innervation of ventricles much less than atria)


Respiratory effects l.jpg
Respiratory Effects

  • bronchial smooth muscle contraction

  • respiratory gland secretion

  • asthmatics highly sensitive


Gi effects l.jpg
GI Effects

  • Increased secretion

    • gastric glands

    • salivary glands

  • Increased motility - diarrhea


Cholinergic receptors in the brain l.jpg
Cholinergic receptors in the brain

  • Brain has muscarinic receptors

    • Esters don’t penetrate

    • Alkaloids penetrate well

  • Brainstem and spinal cord contain nicotinic receptors

    • Mild alerting from smoking

    • Seizures in overdose


Nicotine l.jpg
Nicotine

  • Complex effects on receptors

    • Agonist effects

      • brain nicotinic receptors

      • ganglionic nicotinic receptors – turns on both PNS and SNS

      • neuromuscular nicotinic receptors – only in overdose

    • Blockade - may produce a “depolarizing block” of nicotinic receptors in high doses


Nicotine31 l.jpg
Nicotine

  • Organ effects

    • Determined by predominate branch of the autonomic nervous system in that organ

    • CV effects - largely sympathetic

      • Increased HR, SV, CO

      • Vasoconstriction of vascular beds

    • GI & Urinary - largely parasympathetic

  • Chronic toxicity is the most serious from a societal point of view


Indirect acting agents l.jpg
Indirect-Acting Agents

  • inhibit Ach’esterase

  • buildup of Ach at ganglia, neuroeffector and neuromuscular junctions

  • amplify effects of endogenous Ach

  • chief use: insecticides


Acetylcholinesterase inhibitors l.jpg
Acetylcholinesterase Inhibitors

1. simple alcohols (edrophonium)

2. carbamic acid esters (neostigmine)

3. organophosphates (isoflurophate)


Enzyme binding l.jpg
Enzyme Binding

  • simple alcohols - bind to enzyme reversibly (edrophonium)

  • carbamates - bond with Ach’ase more long-lasting e.g. 30 mins

  • organophosphates - bond irreversibly; very long acting


Duration of action of cholinesterase inhibitors l.jpg
Duration of Action of Cholinesterase Inhibitors

  • Determined mostly by length of binding to enzyme

    • simple alcohols - short

    • carbamates - intermediate

    • organophosphates - very long



Edrophonium tensilon l.jpg
Edrophonium (Tensilon) inhibitors

  • Short acting alcohol type

  • Uses

    • Diagnosis of myasthenia gravis*

      • Muscle strength tested after administration

      • Marked improvement is a positive test

    • Adequacy of treatment

      *Look up the pathogenesis of myasthenia gravis


Edrophonium tensilon39 l.jpg
Edrophonium (Tensilon) inhibitors

  • Test adequacy of treatment with longer acting agents (e.g. pyridostigmine)

    • Improvement means dose of long acting agent too low

    • No improvement or worsening indicates “depolarizing block” by long-acting agent. Lower dose indicated.


Organophosphates l.jpg
Organophosphates inhibitors

  • phosphorylates Ach’esterase enzyme

  • covalent phosphorus-enzyme bond strong

  • After time the bond “ages” or gets stronger

  • enzyme may be rejuvenated with pralidoxime, esp. before “aging”



Some insecticides l.jpg
Some Insecticides inhibitors

  • Organophosphates

    • chlorpyrifos (Dursban)

    • malathion

    • diazinon

  • Carbamate

    • Carbaryl (Sevin)


Cholinesterase inhibitors l.jpg
Cholinesterase Inhibitors inhibitors

  • CNS - may cause convulsions

  • GI, respiratory, urinary – stimulatory, like direct-acting agents


Cholinesterase inhibitors44 l.jpg
Cholinesterase inhibitors Inhibitors

  • Cardiovascular

    • both sympathetic & parasympathetic stimulation

    • parasympathetic predominate

    • bradycardia, decreased CO, modest fall in BP


Cholinesterase inhibitors45 l.jpg
Cholinesterase Inhibitors inhibitors

  • Skeletal muscle

    • therapeutic doses -

      • moderately prolong Ach

      • intensify Ach actions

    • toxic doses

      • fibrillation of muscle fibers

      • depolarizing blockade and muscle paralysis


Clinical uses of cholinergic agonists l.jpg
Clinical Uses of Cholinergic Agonists inhibitors

  • Glaucoma – physostigmine once used

  • GI and urinary stimulation - bethanechol

  • myasthenia gravis

    • edrophonium for diagnosis or testing

    • pyridostigmine for treatment


Sludge toxicity l.jpg
SLUDGE: Toxicity inhibitors

  • Salivation

  • Lacrimation

  • Urination

  • Defecation

  • Gastric Emptying


Cholinesterase inhibitor toxicity l.jpg
Cholinesterase Inhibitor Toxicity inhibitors

  • approximately 100 organophosphates & 20 carbamate insecticides available

  • SLUDGE

  • convulsions in bad toxicities

  • depolarizating nmj blockade


Cholinergic blockers l.jpg

Cholinergic Blockers inhibitors

More selective than agonists; may block muscarinic or nicotinic receptors selectively

M.R. Zarrindast


Cholinergic blockers50 l.jpg
Cholinergic Blockers inhibitors

  • muscarinic blockers - very useful in medicine

  • ganglionic blockers - not used much

  • neuromuscular blockers - used for skeletal muscle relaxation in surgery


Antimuscarinic drugs l.jpg
Antimuscarinic Drugs inhibitors

  • alkaloids – naturally occurring

    • atropine

    • scopolamine

  • tertiary amines

    • dicyclomine

    • benztropine

  • quaternary amines - ipratropium


Antimuscarinic drugs52 l.jpg
Antimuscarinic Drugs inhibitors

  • tertiary amines & alkaloids

    • lipid soluble

    • good absorption from mucous membranes and skin

    • penetration into brain

    • wide distribution e.g. brain & periphery

    • highly selective for muscarinic receptor

  • quaternary amines - opposite of above





Atropine scopolamine l.jpg
Atropine & Scopolamine genitourinary conditions

  • plant origin

    • atropine - Atropa belladonna

    • scopolamine - Hyoscyamus niger

  • well absorbed from mucous membranes or skin

  • competes with Ach for muscarinic receptors

  • organs differ in sensitivity to these drugs


Atropine l.jpg
Atropine genitourinary conditions

  • most sensitive

    • salivary glands

    • bronchial glands

    • sweat glands

  • intermediate sensitivity - heart tissues

  • least sensitive - parietal cells

  • highly selective for muscarinic receptors


Atropine cns l.jpg
Atropine - CNS genitourinary conditions

  • sedation in therapeutic doses

  • hallucinations in toxic doses

  • bradycardia when given parenterally

  • antimotion sickness effects

  • antiparkinsonism effects


Atropine eye l.jpg
Atropine - Eye genitourinary conditions

  • relaxes pupillary sphincter muscle

    • unopposed sympathetic effects

    • mydriasis or dilation

  • paralysis of the ciliary muscle - cycloplegia

  • reduction in lacrimal secretion - dry eye


Atropine heart cardiovascular system l.jpg
Atropine genitourinary conditionsHeart & Cardiovascular System

  • initial bradycardia - central effect (?)

  • tachycardia due to blockade of vagal slowing

    • Opposes ach effects on SA depolarization

    • Opposes ach effects on AV conduction

  • ventricles are less affected

  • overall - little affect on BP


Atropine61 l.jpg
Atropine genitourinary conditions

  • respiratory tract

    • some bronchodilation

    • reduction of respiratory secretions

    • a quaternary drug (Ipatropium) is given as an aerosol to patients with asthma

  • genitourinary tract - ureter and bladder relaxation

  • sweat glands - suppressed by atropine


Atropine62 l.jpg
Atropine genitourinary conditions

  • dry mouth

  • slight, if any, decrease in gastric secretion

  • GI motility decreased

    • decreased gastric emptying

    • constipation


Anticholinergics contraindications l.jpg
Anticholinergics: Contraindications genitourinary conditions

  • Glaucoma

  • Urinary retention esp. in patients with Begnin prostatic hypertrophic


Atropine poisoning l.jpg
Atropine Poisoning genitourinary conditions

  • dry as a bone

  • blind as a bat

  • red as a beet

  • very dangerous in children - hyperpyrexia


Therapeutic uses l.jpg
Therapeutic Uses genitourinary conditions

  • antiparkinsonism effects

  • motion sickness - scopolamine given via transdermal patch

  • eye examinations - usually something short-acting (e.g. phenylephrine) is used rather than atropine

  • asthma - ipatropium aerosol

  • insecticide poisoning


Ganglionic blockers l.jpg

Ganglionic Blockers genitourinary conditions

block the action of Ach and similar agonists at nicotinic receptors at both sympathetic and parasympathetic ganglia


Ganglionic blockers67 l.jpg
Ganglionic Blockers genitourinary conditions

  • lack of selectivity

  • almost completely abandoned for clinical use

  • used for short-term reduction of BP

  • agents

    • mecamylamine – only one available in the US

    • trimethaphan


Ganglionic blockers68 l.jpg
Ganglionic Blockers genitourinary conditions

  • trimethaphan is devoid of CNS effects

  • mecamylamine is not

    • sedation, tremor, choreiform movements

  • eye

    • cycloplegia

    • pupil variously affected

  • BP decreased - highly orthostatic


Neuromuscular blockers l.jpg

Neuromuscular Blockers genitourinary conditions


Neuromuscular blockers70 l.jpg
Neuromuscular Blockers genitourinary conditions

  • interfere with transmission at the nmj

  • used as adjuncts to general anesthesia

  • 2 types

    • non-depolarizing - typified by tubocurarine

    • depolarizing - typified by succinylcholine


Slide71 l.jpg

Neuromuscular transmission genitourinary conditions

axon

ach’esterase

ach receptors

nerve terminal

muscle

muscle

End-plate


Curare l.jpg
Curare genitourinary conditions

  • South American Indian arrow poison

  • crude material called curare

  • active principle is tubocurarine

  • polar, water soluble

  • prevents access of ach to its receptor (competitive antagonist)

  • prevents depolarization of end-plate

  • relaxes skeletal muscles


Tubocurarine l.jpg
Tubocurarine genitourinary conditions

  • limited distribution in the body

  • acts for > 30 mins

  • jaw & eye paralyzed first

  • larger muscle (trunk & limbs) paralyzed second

  • diaphragm paralyzed last

  • releases histamine - lowers BP


Other non depolarizing agents l.jpg
Other Non-depolarizing Agents genitourinary conditions

  • Atracurium

  • doxacurium

  • mivacurium

  • pancuronium

  • vecuronium

  • pipecuronium

  • rocuronium


Depolarizing type succinylcholine l.jpg
Depolarizing type: Succinylcholine genitourinary conditions

  • consists of 2 Ach molecules end-to-end

  • produces a depolarizing block

    • phase I - depolarizes the end-plate & adjacent muscle

    • phase II - with continued presence, it desensitizes the end-plate to Ach

  • metabolized by plasma pseudocholinesterases


Succinylcholine l.jpg
Succinylcholine genitourinary conditions

  • not metabolized at the nmj

  • plasma cholinesterase determines

    • concentration that reaches the nmj

    • duration of action

  • some people have atypical cholinesterase and can’t metabolize succinylcholine; they over-react to the drug

  • block lasts only 10 to 15 minutes in normal patients

  • blockade NOT overcome by Ach or ach’esterase inhibitors


Depolarizating blockers adverse effects l.jpg
Depolarizating Blockers genitourinary conditionsadverse effects

  • hyperkalemia - not well understood

  • increased intraocular pressure

  • increased intragastric pressure

  • muscle pain - presumably because of the unsynchronized contractions just before paralysis